O4‐02–06: Blocking Tgf‐β‐smad 2/3 innate immune signaling mitigates Alzheimer‐like pathology in transgenic mice
Town T, Laouar Y, Pittenger C, Mori T, Szekely C, Tan J, Duman R, Flavell R. O4‐02–06: Blocking Tgf‐β‐smad 2/3 innate immune signaling mitigates Alzheimer‐like pathology in transgenic mice. Alzheimer's & Dementia 2008, 4: t187-t188. DOI: 10.1016/j.jalz.2008.05.514.Peer-Reviewed Original Research